<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.nature.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.nature.com/nrrheum/current_issue/rss">
<title>Nature Reviews Rheumatology - Issue - nature.com science feeds</title>
<description>Nature Reviews Rheumatology provides physicians and academics with authoritative and topical discussions of key developments in the field.</description>
<link>http://www.nature.com/nrrheum/current_issue/</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>© 2009 Nature Publishing Group</dc:rights>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:issn>1759-4790</prism:issn>
<prism:eIssn>1759-4804</prism:eIssn>
<prism:copyright>© 2009 Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/includes/rj_globnavimages/nrrheum_logo.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.199" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.198" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.205" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.200" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.201" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.202" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.211" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.215" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.213" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.212" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.214" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.204" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.207" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.209" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.203" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.210" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.208" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.196" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.nature.com/nrrheum/rss/current" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /></channel>
<image rdf:about="http://www.nature.com/includes/rj_globnavimages/nrrheum_logo.gif">
<title>Nature Reviews Rheumatology</title>
<url>http://www.nature.com/includes/rj_globnavimages/nrrheum_logo.gif</url>
<link>http://www.nature.com/nrrheum/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.199">
<title>Bone: Bony spur formation in inflammatory arthritis: an active and independent process</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/grgyXHZibSw/nrrheum.2009.199</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Bone: Bony spur formation in inflammatory arthritis: an active and independent process</b>
</p>
<p>Nature Reviews Rheumatology 5, 589 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.199">doi:10.1038/nrrheum.2009.199</a>
</p>
<p>Author: Katrin Legg</p>
<p/>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/grgyXHZibSw" height="1" width="1"/>]]></content:encoded>
<dc:title>Bone: Bony spur formation in inflammatory arthritis: an active and independent process</dc:title>
<dc:creator>Katrin Legg</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.199</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 589 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.199</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.199</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Research Highlight</prism:section>
<prism:startingPage>589</prism:startingPage>
<prism:endingPage>589</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.199</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.198">
<title>Experimental arthritis: Is CD70 a new therapeutic target?</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/MVQXhLcE5vY/nrrheum.2009.198</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Experimental arthritis: Is CD70 a new therapeutic target?</b>
</p>
<p>Nature Reviews Rheumatology 5, 590 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.198">doi:10.1038/nrrheum.2009.198</a>
</p>
<p>Author: Negin Nassabeh</p>
<p/>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/MVQXhLcE5vY" height="1" width="1"/>]]></content:encoded>
<dc:title>Experimental arthritis: Is CD70 a new therapeutic target?</dc:title>
<dc:creator>Negin Nassabeh</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.198</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 590 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.198</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.198</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Research Highlight</prism:section>
<prism:startingPage>590</prism:startingPage>
<prism:endingPage>590</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.198</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.205">
<title>Pharma news: Adalimumab for AS</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/zNTx0ohCLcA/nrrheum.2009.205</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Pharma news: Adalimumab for AS</b>
</p>
<p>Nature Reviews Rheumatology 5, 590 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.205">doi:10.1038/nrrheum.2009.205</a>
</p>
<p>Author: Jenny Buckland</p>
<p/>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/zNTx0ohCLcA" height="1" width="1"/>]]></content:encoded>
<dc:title>Pharma news: Adalimumab for AS</dc:title>
<dc:creator>Jenny Buckland</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.205</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 590 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.205</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.205</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Research Highlight</prism:section>
<prism:startingPage>590</prism:startingPage>
<prism:endingPage>590</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.205</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.200">
<title>Fibromyalgia: A quicker, simpler Fibromyalgia Impact Questionnaire</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/iZLOpODgouw/nrrheum.2009.200</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Fibromyalgia: A quicker, simpler Fibromyalgia Impact Questionnaire</b>
</p>
<p>Nature Reviews Rheumatology 5, 591 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.200">doi:10.1038/nrrheum.2009.200</a>
</p>
<p>Author: Sarah Price</p>
<p/>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/iZLOpODgouw" height="1" width="1"/>]]></content:encoded>
<dc:title>Fibromyalgia: A quicker, simpler Fibromyalgia Impact Questionnaire</dc:title>
<dc:creator>Sarah Price</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.200</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 591 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.200</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.200</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Research Highlight</prism:section>
<prism:startingPage>591</prism:startingPage>
<prism:endingPage>591</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.200</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.201">
<title>Bone: Dual role for cannabinoid receptor in bone metabolism</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/CH3uCkpMX-8/nrrheum.2009.201</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Bone: Dual role for cannabinoid receptor in bone metabolism</b>
</p>
<p>Nature Reviews Rheumatology 5, 591 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.201">doi:10.1038/nrrheum.2009.201</a>
</p>
<p>Author: Sarah Price</p>
<p/>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/CH3uCkpMX-8" height="1" width="1"/>]]></content:encoded>
<dc:title>Bone: Dual role for cannabinoid receptor in bone metabolism</dc:title>
<dc:creator>Sarah Price</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.201</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 591 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.201</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.201</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Research Highlight</prism:section>
<prism:startingPage>591</prism:startingPage>
<prism:endingPage>591</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.201</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.202">
<title>Psoriasis: IL-21 blockade—a new therapeutic approach for psoriasis?</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/QGOysTYeRWU/nrrheum.2009.202</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Psoriasis: IL-21 blockade&#8212;a new therapeutic approach for psoriasis?</b>
</p>
<p>Nature Reviews Rheumatology 5, 592 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.202">doi:10.1038/nrrheum.2009.202</a>
</p>
<p>Author: Jenny Buckland</p>
<p/>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/QGOysTYeRWU" height="1" width="1"/>]]></content:encoded>
<dc:title>Psoriasis: IL-21 blockade—a new therapeutic approach for psoriasis?</dc:title>
<dc:creator>Jenny Buckland</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.202</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 592 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.202</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.202</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Research Highlight</prism:section>
<prism:startingPage>592</prism:startingPage>
<prism:endingPage>592</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.202</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.211">
<title>In brief</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/vFl3HhiCCpM/nrrheum.2009.211</link>
<description>Connective tissue diseasesN-acetylcysteine is known to be effective for the short-term treatment of digital ulcers and Raynaud phenomenon in patients with systemic sclerosis; Rosato  et al. have now shown that the agent also has beneficial long-term effects. In 50 consecutive patients </description>
<content:encoded><![CDATA[

<p>
<b>In brief</b>
</p>
<p>Nature Reviews Rheumatology 5, 592 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.211">doi:10.1038/nrrheum.2009.211</a>
</p>
<p>Connective tissue diseasesN-acetylcysteine is known to be effective for the short-term treatment of digital ulcers and Raynaud phenomenon in patients with systemic sclerosis; Rosato  et al. have now shown that the agent also has beneficial long-term effects. In 50 consecutive patients </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/vFl3HhiCCpM" height="1" width="1"/>]]></content:encoded>
<dc:title>In brief</dc:title>
<dc:identifier>doi:10.1038/nrrheum.2009.211</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 592 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.211</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.211</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Research Highlight</prism:section>
<prism:startingPage>592</prism:startingPage>
<prism:endingPage>592</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.211</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.215">
<title>Pediatric rheumatic disease: Can molecular profiling predict the future in JIA?</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/3-0yRiDma00/nrrheum.2009.215</link>
<description>Transcriptomics and proteomics are transforming our understanding of juvenile idiopathic arthritis by revealing molecular signatures associated with the various clinical classifications. The challenge now is to find biomarkers that will predict disease course and response to medication in order to improve outcomes for children with arthritis.</description>
<content:encoded><![CDATA[

<p>
<b>Pediatric rheumatic disease: Can molecular profiling predict the future in JIA?</b>
</p>
<p>Nature Reviews Rheumatology 5, 593 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.215">doi:10.1038/nrrheum.2009.215</a>
</p>
<p>Authors: Patricia J. Hunter &amp; Lucy R. Wedderburn</p>
<p>Transcriptomics and proteomics are transforming our understanding of juvenile idiopathic arthritis by revealing molecular signatures associated with the various clinical classifications. The challenge now is to find biomarkers that will predict disease course and response to medication in order to improve outcomes for children with arthritis.</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/3-0yRiDma00" height="1" width="1"/>]]></content:encoded>
<dc:title>Pediatric rheumatic disease: Can molecular profiling predict the future in JIA?</dc:title>
<dc:creator>Patricia J. Hunter</dc:creator>
<dc:creator>Lucy R. Wedderburn</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.215</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 593 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.215</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.215</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>593</prism:startingPage>
<prism:endingPage>594</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.215</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.213">
<title>Acute inflammatory arthritis: Interleukin-1 blockade: a magic wand for gout?</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/PEXpjXMU_Gk/nrrheum.2009.213</link>
<description>Insight into the immunopathogenesis of crystal-induced inflammation has opened the door to a new approach to therapy. Could interleukin-1 antagonists be the answer to managing acute gout?</description>
<content:encoded><![CDATA[

<p>
<b>Acute inflammatory arthritis: Interleukin-1 blockade: a magic wand for gout?</b>
</p>
<p>Nature Reviews Rheumatology 5, 594 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.213">doi:10.1038/nrrheum.2009.213</a>
</p>
<p>Author: Thomas Bardin</p>
<p>Insight into the immunopathogenesis of crystal-induced inflammation has opened the door to a new approach to therapy. Could interleukin-1 antagonists be the answer to managing acute gout?</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/PEXpjXMU_Gk" height="1" width="1"/>]]></content:encoded>
<dc:title>Acute inflammatory arthritis: Interleukin-1 blockade: a magic wand for gout?</dc:title>
<dc:creator>Thomas Bardin</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.213</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 594 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.213</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.213</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>594</prism:startingPage>
<prism:endingPage>596</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.213</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.212">
<title>Therapy: What should we do after the failure of a first anti-TNF?</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/wiLzFnibz6Q/nrrheum.2009.212</link>
<description>Golimumab effectively reduces the signs and symptoms of active rheumatoid arthritis in patients who have previously failed treatment with at least one tumor necrosis factor inhibitor. Is it now time to develop strategies for sequential drug administration?</description>
<content:encoded><![CDATA[

<p>
<b>Therapy: What should we do after the failure of a first anti-TNF?</b>
</p>
<p>Nature Reviews Rheumatology 5, 596 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.212">doi:10.1038/nrrheum.2009.212</a>
</p>
<p>Author: Chris Deighton</p>
<p>Golimumab effectively reduces the signs and symptoms of active rheumatoid arthritis in patients who have previously failed treatment with at least one tumor necrosis factor inhibitor. Is it now time to develop strategies for sequential drug administration?</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/wiLzFnibz6Q" height="1" width="1"/>]]></content:encoded>
<dc:title>Therapy: What should we do after the failure of a first anti-TNF?</dc:title>
<dc:creator>Chris Deighton</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.212</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 596 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.212</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.212</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>596</prism:startingPage>
<prism:endingPage>597</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.212</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.214">
<title>Osteoarthritis: More evidence for non-pharmacological OA therapy</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/it3NDhfhGFg/nrrheum.2009.214</link>
<description>Randomized controlled trials investigating non-pharmacological therapies for hand osteoarthritis are rare. One such study now suggests that neoprene splints could be effective for the treatment of base-of-thumb osteoarthritis—but some questions remain unanswered.</description>
<content:encoded><![CDATA[

<p>
<b>Osteoarthritis: More evidence for non-pharmacological OA therapy</b>
</p>
<p>Nature Reviews Rheumatology 5, 597 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.214">doi:10.1038/nrrheum.2009.214</a>
</p>
<p>Author: Maxime Dougados</p>
<p>Randomized controlled trials investigating non-pharmacological therapies for hand osteoarthritis are rare. One such study now suggests that neoprene splints could be effective for the treatment of base-of-thumb osteoarthritis&#8212;but some questions remain unanswered.</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/it3NDhfhGFg" height="1" width="1"/>]]></content:encoded>
<dc:title>Osteoarthritis: More evidence for non-pharmacological OA therapy</dc:title>
<dc:creator>Maxime Dougados</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.214</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 597 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.214</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.214</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>597</prism:startingPage>
<prism:endingPage>598</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.214</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.204">
<title>New methods to diagnose and treat cartilage degeneration</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/JtMjtIt5WGk/nrrheum.2009.204</link>
<description>Lesions in articular cartilage can result in significant musculoskeletal morbidity and display unique biomechanical characteristics that make repair difficult, at best. Several surgical procedures have been devised in an attempt to relieve pain, restore function, and delay or stop the progression of cartilaginous lesions. Advanced </description>
<content:encoded><![CDATA[

<p>
<b>New methods to diagnose and treat cartilage degeneration</b>
</p>
<p>Nature Reviews Rheumatology 5, 599 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.204">doi:10.1038/nrrheum.2009.204</a>
</p>
<p>Authors: Robert J. Daher, Nadeen O. Chahine, Andrew S. Greenberg, Nicholas A. Sgaglione &amp; Daniel A. Grande</p>
<p>Lesions in articular cartilage can result in significant musculoskeletal morbidity and display unique biomechanical characteristics that make repair difficult, at best. Several surgical procedures have been devised in an attempt to relieve pain, restore function, and delay or stop the progression of cartilaginous lesions. Advanced </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/JtMjtIt5WGk" height="1" width="1"/>]]></content:encoded>
<dc:title>New methods to diagnose and treat cartilage degeneration</dc:title>
<dc:creator>Robert J. Daher</dc:creator>
<dc:creator>Nadeen O. Chahine</dc:creator>
<dc:creator>Andrew S. Greenberg</dc:creator>
<dc:creator>Nicholas A. Sgaglione</dc:creator>
<dc:creator>Daniel A. Grande</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.204</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 599 (2009)</dc:source>
<dc:date>2009-09-29</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-09-29</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.204</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.204</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>599</prism:startingPage>
<prism:endingPage>607</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.204</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.207">
<title>Tools for monitoring spondyloarthritis in clinical practice</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/ikaonYgQ6ck/nrrheum.2009.207</link>
<description>Spondyloarthritis (SpA) usually follows a chronic disease course that requires regular medical care and monitoring to control for increased disease activity and to maintain physical function. This Review describes the instruments and imaging techniques available for monitoring SpA in clinical practice. Specifically, questionnaires, physical examination </description>
<content:encoded><![CDATA[

<p>
<b>Tools for monitoring spondyloarthritis in clinical practice</b>
</p>
<p>Nature Reviews Rheumatology 5, 608 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.207">doi:10.1038/nrrheum.2009.207</a>
</p>
<p>Authors: Astrid M. van Tubergen &amp; Robert B. M. Landew&#233;</p>
<p>Spondyloarthritis (SpA) usually follows a chronic disease course that requires regular medical care and monitoring to control for increased disease activity and to maintain physical function. This Review describes the instruments and imaging techniques available for monitoring SpA in clinical practice. Specifically, questionnaires, physical examination </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/ikaonYgQ6ck" height="1" width="1"/>]]></content:encoded>
<dc:title>Tools for monitoring spondyloarthritis in clinical practice</dc:title>
<dc:creator>Astrid M. van Tubergen</dc:creator>
<dc:creator>Robert B. M. Landewé</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.207</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 608 (2009)</dc:source>
<dc:date>2009-10-06</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-10-06</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.207</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.207</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>608</prism:startingPage>
<prism:endingPage>615</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.207</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.209">
<title>Oligoarticular and polyarticular JIA: epidemiology and pathogenesis</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/-ZWQBPEr3oU/nrrheum.2009.209</link>
<description>Juvenile idiopathic arthritis (JIA) refers to a group of chronic childhood arthropathies of unknown etiology, currently classified into subtypes primarily on the basis of clinical features. Research has focused on the hypothesis that these subtypes arise through distinct etiologic pathways. In this Review, we discuss </description>
<content:encoded><![CDATA[

<p>
<b>Oligoarticular and polyarticular JIA: epidemiology and pathogenesis</b>
</p>
<p>Nature Reviews Rheumatology 5, 616 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.209">doi:10.1038/nrrheum.2009.209</a>
</p>
<p>Authors: Claudia Macaubas, Khoa Nguyen, Diana Milojevic, Jane L. Park &amp; Elizabeth D. Mellins</p>
<p>Juvenile idiopathic arthritis (JIA) refers to a group of chronic childhood arthropathies of unknown etiology, currently classified into subtypes primarily on the basis of clinical features. Research has focused on the hypothesis that these subtypes arise through distinct etiologic pathways. In this Review, we discuss </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/-ZWQBPEr3oU" height="1" width="1"/>]]></content:encoded>
<dc:title>Oligoarticular and polyarticular JIA: epidemiology and pathogenesis</dc:title>
<dc:creator>Claudia Macaubas</dc:creator>
<dc:creator>Khoa Nguyen</dc:creator>
<dc:creator>Diana Milojevic</dc:creator>
<dc:creator>Jane L. Park</dc:creator>
<dc:creator>Elizabeth D. Mellins</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.209</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 616 (2009)</dc:source>
<dc:date>2009-10-06</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-10-06</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.209</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.209</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>616</prism:startingPage>
<prism:endingPage>626</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.209</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.203">
<title>Clinical approaches to early inflammatory arthritis</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/tlivvRnyS9o/nrrheum.2009.203</link>
<description>Several advances have been made in the understanding of the pathogenesis, as well as in the clinical evaluation and treatment, of early inflammatory arthritis. The presence of anti-citrullinated protein antibodies (ACPAs) has emerged as a major new biomarker for use in clinical practice. The presence </description>
<content:encoded><![CDATA[

<p>
<b>Clinical approaches to early inflammatory arthritis</b>
</p>
<p>Nature Reviews Rheumatology 5, 627 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.203">doi:10.1038/nrrheum.2009.203</a>
</p>
<p>Authors: Dirkjan van Schaardenburg &amp; Ben A. C. Dijkmans</p>
<p>Several advances have been made in the understanding of the pathogenesis, as well as in the clinical evaluation and treatment, of early inflammatory arthritis. The presence of anti-citrullinated protein antibodies (ACPAs) has emerged as a major new biomarker for use in clinical practice. The presence </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/tlivvRnyS9o" height="1" width="1"/>]]></content:encoded>
<dc:title>Clinical approaches to early inflammatory arthritis</dc:title>
<dc:creator>Dirkjan van Schaardenburg</dc:creator>
<dc:creator>Ben A. C. Dijkmans</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.203</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 627 (2009)</dc:source>
<dc:date>2009-09-29</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-09-29</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.203</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.203</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>627</prism:startingPage>
<prism:endingPage>633</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.203</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.210">
<title>The diagnosis and treatment of early psoriatic arthritis</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/HRXvsCwhnZQ/nrrheum.2009.210</link>
<description>Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disorder associated with a heterogeneous disease presentation, varied disease expression and an unpredictable but often chronically destructive clinical course. Joint damage can occur early in the disease; indeed, several imaging modalities have demonstrated subclinical joint involvement in </description>
<content:encoded><![CDATA[

<p>
<b>The diagnosis and treatment of early psoriatic arthritis</b>
</p>
<p>Nature Reviews Rheumatology 5, 634 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.210">doi:10.1038/nrrheum.2009.210</a>
</p>
<p>Authors: Allen P. Anandarajah &amp; Christopher T. Ritchlin</p>
<p>Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disorder associated with a heterogeneous disease presentation, varied disease expression and an unpredictable but often chronically destructive clinical course. Joint damage can occur early in the disease; indeed, several imaging modalities have demonstrated subclinical joint involvement in </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/HRXvsCwhnZQ" height="1" width="1"/>]]></content:encoded>
<dc:title>The diagnosis and treatment of early psoriatic arthritis</dc:title>
<dc:creator>Allen P. Anandarajah</dc:creator>
<dc:creator>Christopher T. Ritchlin</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.210</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 634 (2009)</dc:source>
<dc:date>2009-10-06</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-10-06</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.210</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.210</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>634</prism:startingPage>
<prism:endingPage>641</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.210</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.208">
<title>A case of Poncet disease diagnosed with interferon-γ-release assays</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/FLDALvDSDB8/nrrheum.2009.208</link>
<description>Background. A 55-year-old, HLA-B27-positive Finnish woman presented with migratory, sterile polyarthritis.Investigations. Physical examination, chest radiography, serologic testing, microscopy, M. tuberculosis-specific interferon γ enzyme-linked immunospot (ELISPOT) assay, smear and culture of synovial fluid for acid-fast bacilli, and PCR.Diagnosis. The patient's </description>
<content:encoded><![CDATA[

<p>
<b>A case of Poncet disease diagnosed with interferon-&#947;-release assays</b>
</p>
<p>Nature Reviews Rheumatology 5, 643 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.208">doi:10.1038/nrrheum.2009.208</a>
</p>
<p>Authors: Heikki Valleala, Tamara Tuuminen, Heikki Repo, Kari K. Eklund &amp; Marjatta Leirisalo-Repo</p>
<p>Background. A 55-year-old, HLA-B27-positive Finnish woman presented with migratory, sterile polyarthritis.Investigations. Physical examination, chest radiography, serologic testing, microscopy, M. tuberculosis-specific interferon &#947; enzyme-linked immunospot (ELISPOT) assay, smear and culture of synovial fluid for acid-fast bacilli, and PCR.Diagnosis. The patient's </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/FLDALvDSDB8" height="1" width="1"/>]]></content:encoded>
<dc:title>A case of Poncet disease diagnosed with interferon-γ-release assays</dc:title>
<dc:creator>Heikki Valleala</dc:creator>
<dc:creator>Tamara Tuuminen</dc:creator>
<dc:creator>Heikki Repo</dc:creator>
<dc:creator>Kari K. Eklund</dc:creator>
<dc:creator>Marjatta Leirisalo-Repo</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.208</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 643 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.208</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.208</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Case Study</prism:section>
<prism:startingPage>643</prism:startingPage>
<prism:endingPage>647</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.208</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.196">
<title>Vaccines and autoimmunity</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/current/~3/ckqwv2nFYl0/nrrheum.2009.196</link>
<description>Vaccines have been used for over 200 years and are the most effective way of preventing the morbidity and mortality associated with infections. Like other drugs, vaccines can cause adverse events, but unlike conventional medicines, which are prescribed to people who are ill, vaccines are </description>
<content:encoded><![CDATA[

<p>
<b>Vaccines and autoimmunity</b>
</p>
<p>Nature Reviews Rheumatology 5, 648 (2009). <a href="http://dx.doi.org/10.1038/nrrheum.2009.196">doi:10.1038/nrrheum.2009.196</a>
</p>
<p>Authors: Nancy Agmon-Levin, Ziv Paz, Eitan Israeli &amp; Yehuda Shoenfeld</p>
<p>Vaccines have been used for over 200 years and are the most effective way of preventing the morbidity and mortality associated with infections. Like other drugs, vaccines can cause adverse events, but unlike conventional medicines, which are prescribed to people who are ill, vaccines are </p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/current/~4/ckqwv2nFYl0" height="1" width="1"/>]]></content:encoded>
<dc:title>Vaccines and autoimmunity</dc:title>
<dc:creator>Nancy Agmon-Levin</dc:creator>
<dc:creator>Ziv Paz</dc:creator>
<dc:creator>Eitan Israeli</dc:creator>
<dc:creator>Yehuda Shoenfeld</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.196</dc:identifier>
<dc:source>Nature Reviews Rheumatology 5, 648 (2009)</dc:source>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:doi>10.1038/nrrheum.2009.196</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.196</prism:url>
<prism:volume>5</prism:volume>
<prism:number>11</prism:number>
<prism:section>Perspectives</prism:section>
<prism:startingPage>648</prism:startingPage>
<prism:endingPage>652</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.196</feedburner:origLink></item>
</rdf:RDF>
